Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events

PHASE3TerminatedINTERVENTIONAL
Enrollment

3,300

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Thromboembolism
Interventions
DRUG

EXANTA

Trial Locations (125)

Unknown

Research Site, Graz

Research Site, Innsbruck

Research Site, Leoben

Research Site, Neunkirchen

Research Site, Neustadt

Research Site, Sankt Johann in Tirol

Research Site, Viborg

Research Site, Vienna

Research Site, Wels

Research Site, Brussels

Research Site, Ghent

Research Site, Leuven

Research Site, Aarhus

Research Site, Glostrup Municipality

Research Site, Hellerup

Research Site, Herlev

Research Site, Hillerød

Research Site, Holstebro

Research Site, Hvidovre

Research Site, Hørsholm

Research Site, Silkeborg

Research Site, Vejle

Research Site, Hus

Research Site, Jyväskylä

Research Site, Kuopio

Research Site, Oys

Research Site, Tampere

Research Site, Turku

Research Site, Amiens

Research Site, Annecy

Research Site, Caen

Research Site, Créteil

Research Site, Le Kremlin-Bicêtre

Research Site, Montpellier

Research Site, Nice

Research Site, Paris

Research Site, Saint-Etienne

Research Site, Bad Mergentheim

Research Site, Düsseldorf

Research Site, Essen

Research Site, Frankfurt

Research Site, Garmisch-Partenkirchen

Research Site, Halle

Research Site, Rheinfelden

Research Site, Sommerfeld

Research Site, Wiesbaden

Research Site, Budapest

Research Site, Gyula

Research Site, Gyzr

Research Site, Kecskemét

Research Site, Pécs

Research Site, Szeged

Research Site, Székesthérvár

Research Site, Estado de México

Research Site, Guadalajara

Research Site, Mexico City

Research Site, Assen

Research Site, Breda

Research Site, Groningen

Research Site, Hilversum

Research Site, Leeuwarden

Research Site, Sittard

Research Site, Zaandam

Research Site, Zwolle

Research Site, Ålesund

Research Site, Bergen

Research Site, Bodø

Research Site, Drammen

Research Site, Elverum

Research Site, Gjettum

Research Site, Hagavik

Research Site, Kongsberg

Research Site, Kongsvinger

Research Site, Larvik

Research Site, Levanger

Research Site, Lillehammer

Research Site, Nordbyhagen

Research Site, Oslo

Research Site, Skien

Research Site, Stavanger

Research Site, Trondheim

Research Site, Biaystok

Research Site, Bydgoszcz

Research Site, Chojnice

Research Site, Gdansk

Research Site, Lublin

Research Site, Od

Research Site, Warsaw

Research Site, Wrocraw

Research Site, Barreiro

Research Site, Cascais

Research Site, Lisbon

Research Site, Parede

Research Site, Setúbal

Research Site, Torres Vedras

Research Site, Vila Franca de Xira

Research Site, Durban

Research Site, Gauteng

Research Site, Sandton

Research Site, Barcelona

Research Site, Madrid

Research Site, Ourense

Research Site, Santander

Research Site, Valencia

Research Site, Borås

Research Site, Falköping

Research Site, Falun

Research Site, Gothenburg

Research Site, Jönköping

Research Site, Kalmar

Research Site, Kungälv

Research Site, Linköping

Research Site, Lund

Research Site, Mölndal

Research Site, Örebro

Research Site, Skövde

Research Site, Stockholm

Research Site, Uddevalla

Research Site, Uppsala

Research Site, Basel

Research Site, Bern

Research Site, Geneva

Research Site, Lugano

Research Site, Luzem

Research Site, Zurich

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY